Dizal (Jiangsu) Pharmaceutical Co., Ltd.

¥67.12As of Sun 8 Nov 2026, 12:00 UTC
SSE:688192Healthcare
Country China
PE (Fwd) •••
TSR 5Y CAGR 13.05%
Div yield —
ROE 107.35%
Drug Manufacturers (Specialty & Generic)
Beta (5Y) 0.02
PE TTM 9.051
TSR TTM 5.37%
Mkt cap ¥31.22B
ROIC 470.92%
SE Grade™
Value
Quality
Moat
Consensus
Reference
¥78
16.66%
(47.38%)
Hold 9|5|8|2|7
4Q25
1Q26
2Q26
3Q26
Earnings per share¥
0.71
0.73
0.78
0.86
21.58%
19.07%
19.79%
28.33%
Revenue¥B
1.741
1.712
1.764
1.755
9.46%
2.32%
(0.08%)
1.81%
Peers (US$4.680B)
Cap (US$)
PE
Capital
TTM
5Y
10Y
Leveragex
0.730
0.028
0.031
EBIT/Intx
0.252
0.100
0.100
Own earn%
(19.80)
(188.03)
(161.88)
Sh yield%
28.48
53.83
53.99
Owners
Insiders/Inst%
11.86
67.08
Short interest%
2.14
SBC / revenue%
1.41
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
15
Op margin range%
18–26
$1 testx
−0.2
Incr. ROIC%
3